Karkinos - About the company
Karkinos is an acquired company based in Mumbai (India), founded in 2020 by Sundar Raman, R Venkataramanan, Ravi Kant, Deepak Kharwad, Venkataramani Suresh, Sripriya Rao, Manish Sharma, Shahvir Nooryezdan and Manish Thakkar. It operates as an A comprehensive cancer care platform offering various oncology services. Karkinos has raised $58.2M in funding from investors like Mayo Clinic, Tata Group and Reliance Digital Health, with last known valuation of $*****. The company has 33 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like Thyme Care, Daymarkhealth and Carevive.
Company Details
A comprehensive cancer care platform offering various oncology services. The company's services include risk assessment based early screening, consultation with oncologists, care navigator, personalized advanced diagnostics, financial guidance and support.
- Website
- www.karkinos.in/
- Email ID
- *****@karkinos.in
- Phone Number
- +91 **********
- Registered Address
- 9th Floor, Maker Chamber IV, 222, Nariman Point, Nariman Point, Mumbai, Mumbai, Maharashtra, India, 400021
Key Metrics
Founded Year
2020
Location
Mumbai, India
Stage
Acquired
Total Funding
$58.2M in 2 rounds
Latest Funding Round
Last Known Valuation
$***** as on Dec 28, 2024
Investors
Ranked
5th among 33 active competitors
Annual Revenue
₹66.9Cr as on Mar 31, 2025
Employee Count
395 as on Mar 31, 2026
Similar Companies
Exit Details
Acquired by Reliance Industries (Dec 28, 2024)
Legal entities associated with Karkinos
Karkinos is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
KARKINOS HEALTHCARE TECHNOLOGIES KERALA PRIVATE LIMITED CIN: U85300KL2021PTC067305 , India, Strike off | Feb 04, 2021 | $0 (As on Mar 31, 2024) | - | |
KARKINOS HEALTHCARE NORTH EAST PRIVATE LIMITED CIN: U85100MN2021PTC014321 , India, Active | May 27, 2021 | $1.02M (As on Mar 31, 2025) | 70 (As on Dec 31, 2024) | |
KARKINOS HEALTHCARE PRIVATE LIMITED CIN: U93090MH2020PTC342527 , India, Active | Jul 24, 2020 | $7.92M (As on Mar 31, 2025) | 340 (As on Feb 28, 2025) |
Karkinos's acquisition details
Karkinos got acquired by Reliance Industries on Dec 28, 2024 at an acquisition amount of $43.9M.
Click here to take a look at Karkinos's acquisition in detail
Sign up to download Karkinos' company profile
Karkinos's funding and investors
Karkinos has raised a total funding of $58.2M over 2 rounds. Its first funding round was on Oct 08, 2020. Its latest funding round was a Series B round on May 20, 2022 for $*****. 14 investors participated in its latest round. Karkinos has 47 institutional investors and 9 angel investors.
Here is the list of recent funding rounds of Karkinos:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 20, 2022 | 5314434 | Series B | 8249290 | 6663047 | 7409169 | 8784076 |
Oct 08, 2020 | 1102658 | Series A | 7455722 | 4079627 |
View details of Karkinos's funding rounds and investors
Karkinos' founders and board of directors
Founder? Claim ProfileThe founders of Karkinos are Sundar Raman, R Venkataramanan, Ravi Kant, Deepak Kharwad, Venkataramani Suresh, Sripriya Rao, Manish Sharma, Shahvir Nooryezdan and Manish Thakkar. R Venkataramanan is the CEO of Karkinos.
Here are the details of Karkinos' key team members:
- Sundar Raman: Co Founder & Director of Karkinos. They are also an angel investor in 3 startups and serve on the board of 1 company.
- R Venkataramanan: Co-Founder & CEO of Karkinos. They serve on the board of 1 company.
- Ravi Kant: Co-Founder of Karkinos. They serve on the board of 1 company.Contact Info: 1 email address
- Deepak Kharwad: Co-Founder of Karkinos. They serve on the board of 1 company.Contact Info: 1 email address
- Venkataramani Suresh: Co-Founder & CBO of Karkinos.
Karkinos' Board of Directors
Karkinos's board has 5 active members. Sundar Raman, R Venkataramanan, Ravi Kant and Deepak Kharwad are part of team and Ramesh Babu Byrapaneni is independent board member.Here is the list of Karkinos' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 3y 7m | |
Team | - | Current | 5y 8m | |
Team | - | Current | 3y 7m | |
Team | - | Current | 4y 7m | |
Independent board member | - | Current | 3y 7m | |
{edqrak | Independent board member | - | Current | 6y 3m |
dknwkxw | Independent board member | - | Current | 4y 7m |
xqjmvft | Independent board member | - | Current | 5y 1m |
jkvqczr | Independent board member | - | Past | 2y 4m |
ntqzfta | Independent board member | - | Past | 6y 6m |
elnuelk | Independent board member | - | Past | 5y 3m |
y{mjpji | Independent board member | - | Past | 9y 9m |
View details of Karkinos's Founder profiles and Board Members
Karkinos' employee count trend
Karkinos has 395 employees as of Mar 26. Here is Karkinos's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Karkinos's Competitors and alternates
Top competitors of Karkinos include Thyme Care, Daymarkhealth and Carevive. Here is the list of Top 10 competitors of Karkinos, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Thyme Care 2020, Nashville (United States), Series D | Provider of home nursing care services | $275M | 65/100 | |
2nd | ![]() Daymarkhealth 2013, Baton Rouge (United States), Series A | Provider of cancer care support services including symptom management and navigation | $37.5M | 54/100 | |
3rd | Carevive 2013, Philadelphia (United States), Acquired | Provides personalized cancer care plans for patients | $25.2M | 53/100 | |
4th | Navigating Cancer 2008, Seattle (United States), Series D | Patient engagement portal for cancer patients | $41.4M | 49/100 | |
5th | A comprehensive cancer care platform offering various oncology services | $58.2M | 52/100 | ||
6th | Cordata Healthcare Innovations 2002, Cincinnati (United States), Series A | Provider of care coordination solution for Spine and Oncology | $11.4M | 47/100 | |
7th | Solution for developing 3D bolus for cancer patients | $15.5M | 43/100 | ||
8th | Provides symptom reporting and patient monitoring bringing software for cancer care through mobile devices | $1.59M | 39/100 | ||
9th | Provider of teleconsultation services for cancer patients | - | 35/100 | ||
10th | Colla Health 2023, Houston (United States), Funding Raised | Provider of integrated behavioral health solutions for cancer patient support | - | 30/100 |
Looking for more details on Karkinos's competitors? Click here to see the top ones
Karkinos's Investments and acquisitions
Karkinos has made no investments or acquisitions yet.
Reports related to Karkinos
Here is the latest report on Karkinos's sector:
News related to Karkinos
•
IIT-M launches first-of-its-kind cancer genome database to transform cancer research in IndiaBioSpectrum India•Feb 03, 2025•IIT Madras, Karkinos, Herbalife
•
Reliance's USD 981 mn acquisition of Hathway Cable marks its biggest deal in 5 yearsBestMediaInfo•Jan 02, 2025•Reliance Industries, Karkinos
•
•
•
•
SOPHiA GENETICS partners with Karkinos HealthcareIndiaMedToday•Jan 17, 2024•Sophia Genetics, Karkinos
•
•
Karkinos Healthcare Secures Prestigious Dsci Excellence Award 2023Business News This Week•Dec 29, 2023•Karkinos
•
Karkinos, Points for Good collaborate for early cancer detectionMedical Buyer•Nov 20, 2023•Karkinos, Pointsforgood
•
Karkinos Healthcare spotlights genomic profiling challenges at Third Indian Cancer CongressIndiaMedToday•Nov 10, 2023•Karkinos
Are you a Founder ?
FAQs about Karkinos
Explore our recently published companies
- Beyond Horizon Tech - Miri based, 2012 founded, Unfunded company
- MimiX AWC - Tampa based, 2025 founded, Unfunded company
- ABAC Partners - Paris based, 2016 founded, Unfunded company

